# ALS2

## Overview
The ALS2 gene encodes the protein alsin, a guanine nucleotide exchange factor (GEF) that plays a critical role in cellular processes such as endosomal trafficking and cytoskeletal organization. Alsin is characterized by its complex structure, which includes domains such as the RCC1-like domain (RLD), Dbl homology (DH) domain, pleckstrin homology (PH) domain, and vacuolar protein sorting 9 (VPS9) domain, all of which contribute to its function as a GEF (Miceli2022ALS2Related; Otomo2003ALS2). The protein is predominantly expressed in the central nervous system and is essential for neuronal survival and function, particularly through its interactions with small GTPases like Rac1 and Rab5 (Kanekura2005A; Chandran2007Alsin). Mutations in the ALS2 gene are associated with several motor neuron diseases, including infantile-onset ascending hereditary spastic paralysis and juvenile amyotrophic lateral sclerosis, highlighting its clinical significance in neurodegenerative disorders (Miceli2022ALS2Related).

## Structure
The ALS2 protein, also known as alsin, is characterized by a complex molecular structure that includes several key domains contributing to its function as a guanine nucleotide exchange factor (GEF). The primary structure of ALS2 consists of 1657 amino acids, with a molecular weight of approximately 184 kDa (Miceli2022ALS2Related; Otomo2003ALS2). The protein contains three main GEF domains: the RCC1-like domain (RLD), the Dbl homology (DH) domain, and the pleckstrin homology (PH) domain, as well as the vacuolar protein sorting 9 (VPS9) domain (Miceli2022ALS2Related; Otomo2003ALS2).

The RLD forms a seven-bladed propeller structure stabilized by disulfide bridges, which may influence subcellular localization and endosomal association (Miceli2022ALS2Related). The DH domain typically forms an eleven-α-helix bundle, while the PH domain consists of two perpendicular anti-parallel β-sheets followed by a C-terminal amphipathic helix (Miceli2022ALS2Related). The VPS9 domain is crucial for Rab5 activation and forms a layered fold of six α-helices (Miceli2022ALS2Related; Otomo2003ALS2).

Alsin also contains eight MORN motifs, which are thought to be involved in Rab5-GEF activity through association with intracellular membranes (Miceli2022ALS2Related). The protein's structure is essential for its role in endosomal dynamics and motor neuron disease pathogenesis (Otomo2003ALS2).

## Function
The ALS2 gene encodes the protein alsin, which functions as a guanine nucleotide exchange factor (GEF) involved in the regulation of small GTPases, particularly Rac1 and Rab5. Alsin is ubiquitously expressed in the central nervous system and non-neuronal tissues, with the highest expression in the cerebellum and kidney (Chandran2007Alsin). It plays a crucial role in endosomal trafficking, cytoskeletal organization, and neuronal survival. Alsin's interaction with Rac1 is essential for regulating actin dynamics and neuritic outgrowth, suggesting a role in axonal guidance (Kanekura2005A; Chandran2007Alsin).

Alsin contains several domains, including the DH/PH and VPS9 domains, which contribute to its function as a GEF. The VPS9 domain is particularly important for Rab5 activation, which is crucial for endosomal fusion and regulation of G-protein coupled receptors (Miceli2022ALS2Related; Chandran2007Alsin). Alsin's role in endosomal trafficking is further supported by its involvement in the Rab5-mediated pathway, which regulates organelle binding, endosomal fusion, and motility during endocytosis (Miceli2022ALS2Related).

In healthy cells, alsin is involved in maintaining cellular structure and trafficking, contributing to the proper functioning of motor neurons and other cell types. Its activity in the cytoplasm is essential for processes such as endocytosis and cytoskeletal reorganization, which are vital for neuronal communication and survival (Kanekura2005A; Miceli2022ALS2Related).

## Clinical Significance
Mutations in the ALS2 gene are linked to several motor neuron diseases (MNDs), including infantile-onset ascending hereditary spastic paralysis (IAHSP), juvenile primary lateral sclerosis (JPLS), and juvenile amyotrophic lateral sclerosis (JALS). These conditions are characterized by progressive degeneration of motor neurons, with varying symptoms and severity. IAHSP typically presents with spasticity in the lower limbs, progressing to quadriplegia, and symptoms appear in early childhood (Miceli2022ALS2Related). JPLS shares similar symptoms with IAHSP but includes unique features like saccadic gaze paresis (Miceli2022ALS2Related). JALS involves both upper and lower motor neuron degeneration, leading to limb weakness, facial muscle spasticity, and bladder dysfunction (Miceli2022ALS2Related).

ALS2 mutations often result in truncated or unstable alsin proteins, leading to loss of function. For instance, a missense mutation in the RCC1 domain, p.G540E, causes protein mislocalization and disrupts endosomal dynamics, contributing to neurodegeneration (Panzeri2006The). Another mutation, C3115T, results in a stop codon and is associated with infantile-onset ascending spastic paralysis with bulbar involvement (Devon2003The). These mutations are inherited in an autosomal-recessive manner and are often found in consanguineous families (Devon2003The).

## Interactions
ALS2, also known as alsin, is involved in several protein interactions that are crucial for its function as a guanine nucleotide exchange factor (GEF). ALS2 interacts with the small GTPase Rab5, acting as a GEF to facilitate endosomal dynamics and endosome fusion. This interaction is mediated through the C-terminal region of ALS2, which includes the membrane occupation and recognition nexus (MORN) motifs and the vacuolar protein sorting 9 (VPS9) domain (Kunita2004Homooligomerization; Otomo2003ALS2). ALS2 also forms homophilic oligomers through its C-terminal regions, a process essential for its Rab5GEF activity and endosomal localization (Kunita2004Homooligomerization).

ALS2 interacts with Rac1 through its DH and PH domains, activating Rac1 in vivo, although in vitro guanine nucleotide exchange activity on Rac1 was not observed (Topp2004Alsin). This interaction is specific to Rac1, as Rac3 shows little or no interaction (Topp2004Alsin). ALS2 also interacts with ALS2CL, a novel interactor, forming a large heteromeric complex that modulates ALS2-mediated endosome dynamics (SuzukiUtsunomiya2007ALS2CL). ALS2CL affects the subcellular localization and function of ALS2, facilitating its membrane distribution and modulating endosomal dynamics (SuzukiUtsunomiya2007ALS2CL). These interactions highlight ALS2's role in cellular processes related to endosomal trafficking and cytoskeletal organization.


## References


[1. (Kanekura2005A) Kohsuke Kanekura, Yuichi Hashimoto, Yoshiko Kita, Jumpei Sasabe, Sadakazu Aiso, Ikuo Nishimoto, and Masaaki Matsuoka. A rac1/phosphatidylinositol 3-kinase/akt3 anti-apoptotic pathway, triggered by alsinlf, the product of the als2 gene, antagonizes cu/zn-superoxide dismutase (sod1) mutant-induced motoneuronal cell death. Journal of Biological Chemistry, 280(6):4532–4543, February 2005. URL: http://dx.doi.org/10.1074/JBC.M410508200, doi:10.1074/jbc.m410508200. This article has 118 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M410508200)

[2. (Miceli2022ALS2Related) Marcello Miceli, Cécile Exertier, Marco Cavaglià, Elena Gugole, Marta Boccardo, Rossana Rita Casaluci, Noemi Ceccarelli, Alessandra De Maio, Beatrice Vallone, and Marco A. Deriu. Als2-related motor neuron diseases: from symptoms to molecules. Biology, 11(1):77, January 2022. URL: http://dx.doi.org/10.3390/biology11010077, doi:10.3390/biology11010077. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biology11010077)

[3. (Kunita2004Homooligomerization) Ryota Kunita, Asako Otomo, Hikaru Mizumura, Kyoko Suzuki, Junko Showguchi-Miyata, Yoshiko Yanagisawa, Shinji Hadano, and Joh-E Ikeda. Homo-oligomerization of als2 through its unique carboxyl-terminal regions is essential for the als2-associated rab5 guanine nucleotide exchange activity and its regulatory function on endosome trafficking. Journal of Biological Chemistry, 279(37):38626–38635, September 2004. URL: http://dx.doi.org/10.1074/jbc.m406120200, doi:10.1074/jbc.m406120200. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m406120200)

[4. (Otomo2003ALS2) A. Otomo. Als2, a novel guanine nucleotide exchange factor for the small gtpase rab5, is implicated in endosomal dynamics. Human Molecular Genetics, 12(14):1671–1687, July 2003. URL: http://dx.doi.org/10.1093/hmg/ddg184, doi:10.1093/hmg/ddg184. This article has 208 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddg184)

[5. (Panzeri2006The) C. Panzeri. The first als2 missense mutation associated with jpls reveals new aspects of alsin biological function. Brain, 129(7):1710–1719, July 2006. URL: http://dx.doi.org/10.1093/brain/awl104, doi:10.1093/brain/awl104. This article has 72 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awl104)

[6. (Topp2004Alsin) Justin D. Topp, Noah W. Gray, Robert D. Gerard, and Bruce F. Horazdovsky. Alsin is a rab5 and rac1 guanine nucleotide exchange factor. Journal of Biological Chemistry, 279(23):24612–24623, June 2004. URL: http://dx.doi.org/10.1074/jbc.m313504200, doi:10.1074/jbc.m313504200. This article has 158 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m313504200)

[7. (SuzukiUtsunomiya2007ALS2CL) Kyoko Suzuki-Utsunomiya, Shinji Hadano, Asako Otomo, Ryota Kunita, Hikaru Mizumura, Hitoshi Osuga, and Joh-E Ikeda. Als2cl, a novel als2-interactor, modulates als2-mediated endosome dynamics. Biochemical and Biophysical Research Communications, 354(2):491–497, March 2007. URL: http://dx.doi.org/10.1016/j.bbrc.2006.12.229, doi:10.1016/j.bbrc.2006.12.229. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2006.12.229)

[8. (Devon2003The) RS Devon, JR Helm, GA Rouleau, Y Leitner, T Lerman‐Sagie, D Lev, and MR Hayden. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile‐onset ascending spastic paralysis with bulbar involvement in two siblings. Clinical Genetics, 64(3):210–215, August 2003. URL: http://dx.doi.org/10.1034/j.1399-0004.2003.00138.x, doi:10.1034/j.1399-0004.2003.00138.x. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.1034/j.1399-0004.2003.00138.x)

[9. (Chandran2007Alsin) Jayanth Chandran, Jinhui Ding, and Huaibin Cai. Alsin and the molecular pathways of amyotrophic lateral sclerosis. Molecular Neurobiology, 36(3):224–231, July 2007. URL: http://dx.doi.org/10.1007/s12035-007-0034-x, doi:10.1007/s12035-007-0034-x. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-007-0034-x)